共 165 条
- [1] Howden C. W.(1990)Clinical pharmacology of omeprazole Clin. Pharmacokinet. 20 38-40
- [2] Sarisuta N.(1998)Chemical stability and mechanism of degradation of omeprazole Thai. J. Pharm. Sci. 22 81-88
- [3] Tourtip T.(2001)Current status of ATP-ase proton pump inhibitor complexation with cyclodextrins Biolog. J. Armenia. 53 176-193
- [4] Chuarcharoern S.(2004)Cyclodextrin-based pharmaceutics: past, present and future Nat. Rev. Drug Discov. 3 1023-1035
- [5] Marzocchi L.(2004)Cyclodextrins and their uses: a review Process Biochem. 39 1033-1046
- [6] Moyano J. R.(2005)H NMR study of inclusion compounds of phenylurea derivatives in β-cyclodextrin Spectrochim. Acta A 61 1051-1057
- [7] Rossi A.(2005)Preparation of celecoxib-dimethyl-β-cyclodextrin inclusion complex: characterization and Eur. J. Med. Chem. 40 624-631
- [8] Muñoz P.(2005) permeation study AAPS Pharm. Sci. Tech. 6 E329-E357
- [9] Arias M. J.(2003)Cyclodextrins in drug delivery: an updated review Eur. J. Pharm. Sci. 18 285-296
- [10] Giordano F.(1996)Multimodal molecular encapsulation of nicardipine hydrochloride by β-cyclodextrin, hydroxypropyl-β-cyclodextrin and triacetyl-β-cyclodextrin in solution. Structural studies by J. Org. Chem. 61 9578-9581